Compounds > azacitidine

azacitidine and quisinostat

azacitidine has been researched along with quisinostat in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Arts, J; Fang, Z; Garcia-Manero, G; Kuang, SQ; Stevenson, W; Tong, WG; Wei, Y; Zhang, M1
De Bruyne, E; De Raeve, H; De Smedt, E; Lemaire, M; Maes, K; McClue, S; Menu, E; Van Valckenborgh, E; Vanderkerken, K1
De Bruyne, E; De Smedt, E; Hose, D; Kassambara, A; Klein, B; Maes, K; Menu, E; Moreaux, J; Seckinger, A; Van Valckenborgh, E; Vanderkerken, K1

Other Studies

4 other study(ies) available for azacitidine and quisinostat

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor.
    Leukemia research, 2010, Volume: 34, Issue:2

    Topics: Antineoplastic Agents; Azacitidine; Decitabine; Drug Evaluation, Preclinical; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Leukemia; Tumor Cells, Cultured

2010
The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma.
    Oncotarget, 2014, May-30, Volume: 5, Issue:10

    Topics: Animals; Antineoplastic Agents; Apoptosis; Azacitidine; Blotting, Western; Decitabine; Disease Models, Animal; DNA Damage; DNA Repair; Flow Cytometry; Fluorescent Antibody Technique; Homologous Recombination; Humans; Hydroxamic Acids; Mice; Mice, Inbred C57BL; Multiple Myeloma; Real-Time Polymerase Chain Reaction

2014
In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma.
    Oncotarget, 2015, Feb-20, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Computational Biology; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice, Inbred C57BL; Molecular Targeted Therapy; Multiple Myeloma; Transcription, Genetic; Treatment Outcome

2015